Who
Bettina M. Cockroft
Director
Company insider
Files Form 4 as: Director, Annexon; Director, CNS Pharmaceuticals.
In numbers
- Trades disclosed
- 15
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 19 Jan 2022
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 17 Nov 2025filed 19 Nov 2025 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,517 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,000 at $0.00 | filing |
| 8 Apr 2024filed 10 Apr 2024 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,500 | filing |
| 8 Apr 2024filed 10 Apr 2024 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,500 | filing |
| 21 Sep 2023filed 12 Oct 2023 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,475 | filing |
| 21 Sep 2023filed 25 Sep 2023 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,551 | filing |
| 14 Sep 2023filed 12 Oct 2023 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,500 | filing |
| 8 Jun 2023filed 12 Jun 2023 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 5 May 2023filed 10 Aug 2023 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,099 | filing |
| 5 May 2023filed 9 May 2023 | CNSP CNS Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,300 | filing |
| 9 Jun 2022filed 13 Jun 2022 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,000 at $0.00 | filing |
| 19 Jan 2022filed 20 Jan 2022 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.